March 3, 2021Open Access

The Potentially Modifiable Risk Factor in Idiopathic Intracranial Hypertension

SMSusan P. MollanUniversity Hospitals Birmingham NHS Foundation Trust ATAbd A. TahraniBirmingham City University ASAlexandra J. SinclairNIHR Surgical Reconstruction and Microbiology Research Centre

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

New research evaluating the pathophysiology of IIH supports GLP-1 RA as a potential treatment for IIH via weight loss dependent and independent mechanism to directly reduce ICP.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Mollan et al. (Wed,) studied this question.

synapsesocial.com/papers/69dd4d92fb7610310c101e20 https://doi.org/https://doi.org/10.1212/cpj.0000000000001063

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Weight Bias Internalization as an Embodied Process: Understanding How Obesity Stigma Gets Under the Skin2019 · 26 citations
2Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records2015 · 395 citations
3Body composition status and the risk of migraine2017 · 116 citations
4The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement2020 · 167 citations
5Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials2020 · 166 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo